A Study of Sensitizing Potential of Diacerein 1% Ointment in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

March 3, 2018

Study Completion Date

March 3, 2018

Conditions
Healthy
Interventions
DRUG

diacerein 1% ointment

All subjects were exposed to diacerein 1% ointment, vehicle ointment, and 0.9% saline (negative control) at 3 randomly assigned, adjacent skin sites on the infrascapular area of the back 3 times weekly for 3 weeks (9 applications) during the Induction Phase, and one time during the Challenge Phase (10 times in total).

Trial Locations (1)

07410

TKL Research, Fair Lawn

All Listed Sponsors
lead

Castle Creek Pharmaceuticals, LLC

INDUSTRY